Dr Martens stands for “rebellious self-expression”, according to the blurb, so the company is in no position to complain if an independently minded stock market decides to stick the boot in.
Investors’ reaction to Thursday’s half-year numbers was blunt. While the chief executive, Kenny Wilson, warbled about “another strong set of results” and the board raised the dividend to shareholders by 28%, the share price crashed by almost a fifth. It is now 40% below last year’s float price.
